Comprehensive validation of a diagnostic strategy for sequencing genes with one or multiple pseudogenes using pseudoxanthoma elasticum as a model

J Genet Genomics. 2021 Apr 20;48(4):289-299. doi: 10.1016/j.jgg.2021.02.009. Epub 2021 Mar 25.

Abstract

Pseudogenes are frequently encountered noncoding sequences with a high sequence similarity to their protein-coding paralogue. For this reason, their presence is often considered troublesome in molecular diagnostics. In pseudoxanthoma elasticum (PXE), a disease predominantly caused by mutations in ATP-binding cassette family C member 6 (ABCC6), the presence of two pseudogenes complicates the analysis of sequence data. With whole-exome sequencing (WES) becoming the standard of care in molecular diagnostics, we wanted to evaluate whether this technique is as reliable as gene-specific targeted enrichment analysis for the analysis of ABCC6. We established a PCR-based targeted enrichment and next-generation sequencing testing approach and demonstrated that the ABCC6-specific enrichment combined with the applied mapping algorithm overcomes the complication of ABCC6 pseudogene aspecificities, contrary to WES. We propose a time- and cost-efficient diagnostic strategy for comprehensive and accurate molecular genetic testing of PXE, which is highly automatable.

Keywords: ABCC6; Next-generation sequencing; Pseudogenes; Pseudoxanthoma elasticum; Targeted enrichment; Whole-exome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Exome Sequencing
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Multidrug Resistance-Associated Proteins / blood
  • Multidrug Resistance-Associated Proteins / genetics*
  • Mutation / genetics
  • Pathology, Molecular*
  • Pedigree
  • Pseudogenes / genetics*
  • Pseudoxanthoma Elasticum / blood
  • Pseudoxanthoma Elasticum / genetics*
  • Pseudoxanthoma Elasticum / pathology

Substances

  • ABCC6 protein, human
  • Multidrug Resistance-Associated Proteins